Events

Biotech Outsourcing Strategies Congress (BOS), Basel 19-20 June 2018

2 weeks ago

Juniper is delighted to be Gold Sponsor of the annual Biotech Outsourcing Strategies event in Basel, Switzerland, from 19th to 20th June 2018. We will be joining thought leaders in the industry to share experience and knowledge from early stage discovery into late product development. On Wednesday 20th June, at 4.20 p.m, Dr Rob Harris

Advancing Drug Development Forum, San Francisco 14 June 2018

1 month ago

The Advancing Drug Development Forum has confirmed a prestigious line-up of leading industry voices to speak at its inaugural West Coast event ‘Advancing Drug Development Forum – Making the Impossible, Possible’, on June 14, 2018 at the San Francisco Wine School in South San Francisco, CA. Juniper will be joining key opinion leaders in biotech

4th Annual Formulation & Drug Delivery Congress, London 8-9 May 2018

1 month ago

Juniper will be joining a line-up of industry experts at the 4th Annual Formulation & Drug Delivery Congress in London, 8-9 May 2018. Focusing on key innovation in formulation and drug delivery, Dr. Rob Harris, Chief Technical Officer at Juniper Pharma Services, will be chairing the “Advances in Drug Delivery” stream 2 on 8th May.

Interphex, New York April 17-19 2018

2 months ago

Juniper Pharma Services is attending International Pharmaceutical Expo (INTERPHEX), Booth #4115, April 17-19, within the new “Formulation X” section of the event at the Javits Centre in New York. Interphex is the premier event dedicated to pharmaceutical and biotechnology innovation, technology and knowledge from development through commercialisation. The event will bring together inspired professionals with

Spray Drying ECA Conference, Lisbon 10-12 April 2018

2 months ago

Juniper is attending the Spray Drying ECA Conference in Lisbon 10-12 April 2018. Dr Andrew Parker will be presenting on the “Application of spray dried materials in the pharmaceutical industry” at the ECA – European GMP Conference on  Spray Drying in Lisbon, 10-12 April 2018. He will discuss the challenges in pharmaceutical development for small

7th Drug Formulation, Solubility & Bioavailability Summit, Boston 26-28 March, 2018

2 months ago

Juniper will be attending the 7th Drug Formulation, Solubility & Bioavailability Summit in Boston 26-28 March, 2018. Join us to discuss the latest formulation strategies and predictive technologies to accelerate manufacturing, preclinical R&D and time to market. When over 80% of APIs in development are poorly water-soluble, drug companies must rely increasingly on new formulation

Accelerating Paediatric Formulation Development, London 28 March 2018

2 months ago

Wednesday 28th March 2018 – Friends House, Euston Road, London Update on Contemporary Paediatrics and Presentation of Output from SPaeDD-UK Project* The Smart Paediatric Drug Development (SPaeDD) initiative co-funded by Innovate UK (the UK’s Innovation Agency) is a cross company and academic centre initiative to accelerate paediatric formulation development. Established in 2014 and focussed on

Juniper is attending DCAT in New York, 19-22 March 2018

2 months ago

We’re delighted to confirm that Juniper is attending DCAT Week in New York, the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. Contact us to arrange a meeting during DCAT week to discuss your small molecule challenges and find out more about Juniper’s drug formulation development and clinical

New Updates in Drug Formulation & Bioavailability, Copenhagen 21 March 2018

3 months ago

Pharmaceutical formulation impacts the bioavailability of a given drug and is therefore one of the key factors in the successful development of a new medicine. However, many of the drugs in the development pipelines often possess poor physico-chemical properties, which make them difficult to formulate using classic approaches and hence require the use of new

Accelerating Cancer Drug Development, Alderley Park 27 February 2018

3 months ago

Juniper will be attending the “Accelerating Cancer Drug Development – From target to patients” seminar in Alderley Park Conference Centre, Alderley Park, Cheshire. Focusing upon the strengths in the discovery, development and manufacture of cancer medicines in the North of England through to commercialisation (patients), this event will highlight industry, academic and clinical strengths whilst